Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.

Abstract

Despite the prevalence of cancers of the head and neck, survival rates have not changed in the past few decades. Recent work has implicated peptide growth factors and their receptors in the genesis and progression of head and neck squamous cell carcinoma. Opioid growth factor (OGF, [Met5]-enkephalin) is a tonically active, autocrine and/or paracrine… (More)

Topics

Cite this paper

@article{Levin1997ExpressionOT, title={Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.}, author={Roger J Levin and Yulian Wu and Patricia McLaughlin and Ian S. Zagon}, journal={The Laryngoscope}, year={1997}, volume={107 3}, pages={335-9} }